Ovarian Cancer Research Symposium
The Rivkin Center and the American Association for Cancer Research are proud to present the 15th Biennial Ovarian Cancer Research Symposium on September 20-21, 2024 at the Seattle Airport Marriott in Seattle, WA.
Since 1996, this Symposium has brought together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research. We seek to enhance understanding and knowledge, discuss recent innovations in research and treatment, and address pressing concerns of leaders in the clinical and research community.
Ovarian cancer is the leading cause of gynecological cancer-related deaths. Because its symptoms can be easily dismissed, 80% of ovarian cancers are diagnosed in late stages when prognosis is poor. The 5-year survival of epithelial ovarian cancer is 93% if diagnosed in the early, localized state, and plummets to 31% if found in late stages. Understanding the risk factors and improved early detection methods are key to detecting ovarian cancer in its early, more survivable stages. Ovarian cancer’s high recurrence rate also makes deep knowledge of chemoresistance, recurrence, and tumor biology essential.
The Biennial Ovarian Cancer Research Symposium addresses these major needs in ovarian cancer research and treatment with sessions covering novel therapeutics, immune-oncology, tumor microenvironment, early detection, prevention, DNA repair, and rare tumors. We will also hold discussions about health and healthcare disparities and the role of patient advocacy in research.
Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM will be available. Return later for details.
Coming in late March.
For questions, please contact Jackie Lang at email@example.com or (206)490-0847 x104
2022 Ovarian Cancer Research Symposium
To join the Rivkin Center Science email list and receive information for researchers and clinicians about ovarian cancer research grants and symposia, email Jackie Lang, PhD.